Carotid artery stenting: A 2009 update

Current Opinion in Cardiology

Volumn 24, Issue 6, 2009, Pages 528-531

  Zeebregts, Clark J ^a   Meerwaldt, Robbert ^b   Geelkerken, Robert H ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Carotid artery stenting; Carotid endarterectomy; Embolic protection device; Stroke prevention

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGE DISTRIBUTION; ANGIOPLASTY; BRAIN PROTECTION; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; DISEASE REGISTRY; DISEASE SEVERITY; FOLLOW UP; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; INTERNAL CAROTID ARTERY OCCLUSION; MINIMALLY INVASIVE SURGERY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROBABILITY; RESTENOSIS; REVIEW; RISK ASSESSMENT; STENT; STROKE; SURVIVAL TIME;

CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; HUMANS; STENTS; TREATMENT OUTCOME;

EID: 74249105906     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328330c302     Document Type: Review

References (16)

1. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics: 2007 update - a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115:e69-e171.
2. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361:107-116.
3. GALA Trial Collaborative Group. Lewis SC, Warlow CP, Bodenham AR, et al. General anaesthesia versus local anaesthesia of carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet 2008; 372:2132-2142. A large randomized trial reveals current 30-day stroke/MI/death rate after CEA to be 4.5-4.8%, with no difference between local and general anesthesia.
4. Ederle J, Featherstone RL, Brown MM. Percutaneous transluminal angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev 2007:CD000515.
5. van der Vaart MG, Meerwaldt R, Reijnen MM, et al. Endarterectomy or carotid artery stenting: the quest continues. Am J Surg 2008; 195:259-269.
6. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004; 351:1493-1501.
7. Ringleb PA, Allenberg J, Bruckmann H, et al. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised noninferiority trial. Lancet 2006; 368:1239-1247.
8. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355:1660-1671.
9. Zeebregts CJ, Cheshire NJ, Bosiers M, et al. What we learned about trials from the European carotid stent trials. Ann Vasc Surg 2008; 22:159-161.
10. Eckstein HH, Ringleb P, Allenberg JR, et al. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol 2008; 7:893-902. Long-term results of one of the two large European randomized trials showing no significant differences in clinical outcome between CEA and CAS but a higher number of restenoses with CAS.
11. Mas JL, Trinquart L, Leys D, et al., EVA3-S Investigators. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol 2008; 7:885-892. Long-term results of one of the two large randomized European trials showing significant higher rates of any periprocedural stroke or death and any nonprocedural ipsilateral stroke after CAS compared with CEA.
12. Brown MM, Ederle J, Bonati LH, et al., for the ICSS investigators. Safety results of the International Carotid Stenting Study (ICSS): early outcome of patients randomised between carotid stenting and endarterectomy for symptomatic carotid stenosis. In: 18th European Stroke Conference 2009; 26-29 May 2009; Stockholm, Sweden.
13. Sheffet A, Longbottom M, Meschia J, et al. Update on the carotid revascularization endarterectomy versus stenting trial (CREST): when will we have answers and will they be definitive for symptomatic and asymptomatic patients? In: 35th Veith Symposium 2008; 19-23 November 2008; New York, NY.
14. Naylor AR, Gaines PA, Rothwell PM. Who benefits most from intervention for asymptomatic carotid stenosis: patients or professionals? Eur J Vasc Endovasc 2009; 37:625-632.
15. Sillesen H, Amarenco P, Hennerici MG, et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2008; 39:3297-3302. A randomized trial showing that intense lipid lowering with atorvastatin reduced the risk of cerebrovascular and cardiovascular events in patients with and without carotid stenosis, thereby clearly improving the so-called 'best medical treatment'.
16. Wallis de Vries BM, van Dam GM, Tio RA, et al. Current imaging modalities to visualize vulnerability within the atherosclerotic carotid plaque. J Vasc Surg 2008; 48:1620-1629.